Literature DB >> 10764295

Cardiac contractility is not depressed in early canine endotoxic shock.

M R Pinsky1, P Rico.   

Abstract

We investigated effects of acute endotoxemia (Escherichia coli endotoxin, 1 mg/kg, intravenously) on left ventricular (LV) function in the first 4 h after induction of endotoxic shock in anesthetized canine preparations (n = 7 each, endotoxin and control groups). LV pressure and conductance (volume) catheters were used to construct pressure-volume loops. Transient inferior vena cava occlusion was used to rapidly and reversibly alter LV end-diastolic volume. LV contractility was assessed from the slope of the LV end-systolic pressure-volume relationship (Ees) and from preload-recruitable stroke work (PRSW), and from their change (DeltaEes and DeltaPRSW, respectively, measured at 2 and 4 h only), in response to a dobutamine infusion (5 microg/kg/min). Diastolic function and arterial tone were assessed as the maximal negative change in filling pressure versus time (max -dP/dt), filling rate, and arterial elastance (Ea), respectively. Ees, PRSW, Ea, diastolic function, and hemodynamics were measured hourly. Endotoxemia induced an immediate hypotensive, hyperdynamic, tachycardic state with progressive lactic acidosis. By 2.5 h after endotoxin infusion, heart rate returned to preendotoxin and control levels, but the other changes remained. However, no change occurred in LV Ees, DeltaEes, PRSW, DeltaPRSW, diastolic function, or Ea during the 4-h measurement interval. The cardiovascular collapse seen during the first 4 h of endotoxemia is therefore not due even partly to alterations in LV contractility.

Entities:  

Mesh:

Year:  2000        PMID: 10764295     DOI: 10.1164/ajrccm.161.4.9904033

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism.

Authors:  Li Jianhui; Nathalie Rosenblatt-Velin; Noureddine Loukili; Pal Pacher; François Feihl; Bernard Waeber; Lucas Liaudet
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-04       Impact factor: 4.733

2.  Differential Effects of Ventricular Pacing Sites of Contraction Synchrony and Global Cardiac Performance.

Authors:  Mohammed Alhammouri; Hyung Kook Kim; Yasser Mokhtar; Maxime Cannesson; Masaki Tanabe; John Gorcsan; David Schwartzman; Michael R Pinsky
Journal:  Crit Care Shock       Date:  2009-05-01

Review 3.  The interface between monitoring and physiology at the bedside.

Authors:  Eliezer L Bose; Marilyn Hravnak; Michael R Pinsky
Journal:  Crit Care Clin       Date:  2015-01       Impact factor: 3.598

4.  HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

Authors:  Geeta Datta; Himanshu Gupta; Zhenghao Zhang; Palgunachari Mayakonda; G M Anantharamaiah; C Roger White
Journal:  J Clin Exp Cardiolog       Date:  2011-12-22

5.  Bacterial flagellin triggers cardiac innate immune responses and acute contractile dysfunction.

Authors:  Joelle Rolli; Nathalie Rosenblatt-Velin; Jianhui Li; Noureddine Loukili; Sandra Levrand; Pal Pacher; Bernard Waeber; François Feihl; Patrick Ruchat; Lucas Liaudet
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

6.  Is myocardial adrenergic responsiveness depressed in human septic shock?

Authors:  Alain Cariou; Michael R Pinsky; Mehran Monchi; Ivan Laurent; Christophe Vinsonneau; Jean-Daniel Chiche; Julien Charpentier; Jean-François Dhainaut
Journal:  Intensive Care Med       Date:  2008-02-08       Impact factor: 17.440

7.  Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis.

Authors:  F Sanfilippo; C Corredor; N Fletcher; L Tritapepe; F L Lorini; A Arcadipane; A Vieillard-Baron; M Cecconi
Journal:  Crit Care       Date:  2018-08-04       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.